CS
Christine Sekaggya‐Wiltshire

Publications (7)

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)
Article scientifique · 2020
Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study
Article scientifique · 2019
Increasing retention of HIV positive pregnant and breastfeeding mothers on option-b plus by upgrading and providing full time HIV services at a lower health facility in rural Uganda
Article scientifique · 2019
Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort
Article scientifique · 2018
Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
Article scientifique · 2017
Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study
Article scientifique · 2017
Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis
Article scientifique · 2017

Domaines principaux

Sciences de la santé7

Statistiques

Consultations14
Téléchargements0